These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 36083323)

  • 1. Risk factors for development of superior limbic keratoconjunctivitis in thyroid eye disease in Japanese.
    Takahashi Y; Vaidya A; Kakizaki H
    Graefes Arch Clin Exp Ophthalmol; 2023 Mar; 261(3):833-839. PubMed ID: 36083323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tear film break-up patterns in thyroid eye disease.
    Takahashi Y; Lee PAL; Vaidya A; Kono S; Kakizaki H
    Sci Rep; 2021 Mar; 11(1):5288. PubMed ID: 33674648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical rebamipide treatment for superior limbic keratoconjunctivitis in patients with thyroid eye disease.
    Takahashi Y; Ichinose A; Kakizaki H
    Am J Ophthalmol; 2014 Apr; 157(4):807-812.e2. PubMed ID: 24412123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in Eyelid Pressure and Dry Eye Status after Orbital Decompression in Thyroid Eye Disease.
    Takahashi Y; Vaidya A; Kakizaki H
    J Clin Med; 2021 Aug; 10(16):. PubMed ID: 34441983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in Dry Eye Status after Steroid Pulse and Orbital Radiation Therapies in Active Thyroid Eye Disease.
    Takahashi Y; Vaidya A; Kakizaki H
    J Clin Med; 2022 Jun; 11(13):. PubMed ID: 35806890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Superior limbic keratoconjunctivitis: a comprehensive review.
    Lahoti S; Weiss M; Johnson DA; Kheirkhah A
    Surv Ophthalmol; 2022; 67(2):331-341. PubMed ID: 34077767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural history of inflammatory and non-inflammatory dry eye in thyroid eye disease.
    Lo C; Yang M; Rootman D
    Orbit; 2021 Oct; 40(5):389-393. PubMed ID: 32847459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recharacterization of superior limbic keratoconjunctivitis via a subdividing grading method in 236 Chinese patients.
    Cheng C; Zhu M; Lin T; Chen Z; Zeng W; Li K; Xue R; Duan F; Wu K
    Graefes Arch Clin Exp Ophthalmol; 2022 Jul; 260(7):2291-2298. PubMed ID: 35113250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dry eye syndrome in thyroid eye disease patients: The role of increased incomplete blinking and Meibomian gland loss.
    Park J; Baek S
    Acta Ophthalmol; 2019 Aug; 97(5):e800-e806. PubMed ID: 30593716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Severity Classification using Automated Conjunctival Hyperemia Analysis Software in Patients with Superior Limbic Keratoconjunctivitis.
    Kurita J; Shoji J; Inada N; Yoneda T; Sumi T; Kobayashi M; Hoshikawa Y; Fukushima A; Yamagami S
    Curr Eye Res; 2018 Jun; 43(6):679-682. PubMed ID: 29336627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tear cytokine profiling in patients with superior limbic keratoconjunctivitis who underwent medical treatment or in conjunction with surgical management.
    Sun YC; Tang YH; Liou HM; Chen WL; Hu FR
    Br J Ophthalmol; 2020 May; 104(5):735-740. PubMed ID: 30926588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional and structural evaluation of the meibomian gland using a LipiView interferometer in thyroid eye disease.
    Park J; Kim J; Lee H; Park M; Baek S
    Can J Ophthalmol; 2018 Aug; 53(4):373-379. PubMed ID: 30119792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superior Limbic Keratoconjunctivitis-like Inflammation in Patients with Chronic Graft-Versus-Host Disease.
    Sivaraman KR; Jivrajka RV; Soin K; Bouchard CS; Movahedan A; Shorter E; Jain S; Jacobs DS; Djalilian AR
    Ocul Surf; 2016 Jul; 14(3):393-400. PubMed ID: 27179980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the clinical effects of carbomer-based lipid-containing gel and hydroxypropyl-guar gel artificial tear formulations in patients with dry eye syndrome: a 4-week, prospective, open-label, randomized, parallel-group, noninferiority study.
    Wang TJ; Wang IJ; Ho JD; Chou HC; Lin SY; Huang MC
    Clin Ther; 2010 Jan; 32(1):44-52. PubMed ID: 20171410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study to assess the clinical use of Fluorescein Meniscus Time (FMT) with Tear Break up Time (TBUT) and Schirmer's tests (ST) in the diagnosis of dry eyes.
    Kallarackal GU; Ansari EA; Amos N; Martin JC; Lane C; Camilleri JP
    Eye (Lond); 2002 Sep; 16(5):594-600. PubMed ID: 12194075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical cyclosporine A for the dry eye findings of thyroid orbitopathy patients.
    Altiparmak UE; Acar DE; Ozer PA; Emec SD; Kasim R; Ustun H; Duman S
    Eye (Lond); 2010 Jun; 24(6):1044-50. PubMed ID: 19834507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of Meibomian Gland Dysfunction and Friction-Related Disease on the Severity of Dry Eye.
    Vu CHV; Kawashima M; Yamada M; Suwaki K; Uchino M; Shigeyasu C; Hiratsuka Y; Yokoi N; Tsubota K;
    Ophthalmology; 2018 Aug; 125(8):1181-1188. PubMed ID: 29459039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of superior limbic keratoconjunctivitis after upper eyelid blepharoplasty surgery: support for the mechanical theory of its pathogenesis.
    Sheu MC; Schoenfield L; Jeng BH
    Cornea; 2007 May; 26(4):490-2. PubMed ID: 17457203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superior limbic keratoconjunctivitis. A prognostic sign for severe Graves ophthalmopathy.
    Kadrmas EF; Bartley GB
    Ophthalmology; 1995 Oct; 102(10):1472-5. PubMed ID: 9097794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subjective versus objective dry eye disease in patients with moderate-severe thyroid eye disease.
    Kashkouli MB; Alemzadeh SA; Aghaei H; Pakdel F; Abdolalizadeh P; Ghazizadeh M; Moradpasandi F
    Ocul Surf; 2018 Oct; 16(4):458-462. PubMed ID: 30297028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.